Physiomics Plc – LSE:PYC.L

Physiomics stock price today

GBP 6.3
+5.5
+687.5%
Financial Health
0
1
2
3
4
5
6
7
8
9

Physiomics stock price monthly change

+18.52%
month

Physiomics stock price quarterly change

+18.52%
quarter

Physiomics stock price yearly change

-50.00%
year

Physiomics key metrics

Market Cap
1.45M
Enterprise value
N/A
P/E
-29.57
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
2.38
Price/Book
2.50
PEG ratio
-2.21
EPS
N/A
Revenue
1.31M
EBITDA
-1.01M
Income
-826.08K
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-8.06%
Oper. margin
-16.82%
Gross margin
0%
EBIT margin
-16.82%
EBITDA margin
-77.51%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Physiomics stock price history

Physiomics stock forecast

Physiomics financial statements

Physiomics Plc (LSE:PYC.L): Profit margin
Jun 2021 339.31K -142.82K -42.09%
Dec 2022 338K -232K -68.64%
Jun 2023 259.35K -245.25K -94.56%
Dec 2023 374K -206K -55.08%
Physiomics Plc (LSE:PYC.L): Debt to assets
Jun 2021 1323284 157.57K 11.91%
Dec 2021 1299000 219K 16.86%
Dec 2022 961000 199K 20.71%
Dec 2023 793000 121K 15.26%
Physiomics Plc (LSE:PYC.L): Cash Flow
Dec 2021 -242K -7K 0
Dec 2022 -186K -4K 0
Jun 2023 -78.86K -2.21K 0
Dec 2023 -351K -1K 338K

Physiomics alternative data

Physiomics Plc (LSE:PYC.L): Employee count
Aug 2023 8
Sep 2023 8
Oct 2023 8
Nov 2023 10
Dec 2023 10
Jan 2024 10
Feb 2024 10
Mar 2024 10
Apr 2024 10
May 2024 10
Jun 2024 10
Jul 2024 10

Physiomics other data

Insider Compensation
Dr. James Simon Millen (1969) Chief Executive Officer & Director
$146,080
  • What's the price of Physiomics stock today?

    One share of Physiomics stock can currently be purchased for approximately $6.3.

  • When is Physiomics's next earnings date?

    Unfortunately, Physiomics's (PYC.L) next earnings date is currently unknown.

  • Does Physiomics pay dividends?

    No, Physiomics does not pay dividends.

  • How much money does Physiomics make?

    Physiomics has a market capitalization of 1.45M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 34.57% to 543.25K US dollars.

  • What is Physiomics's stock symbol?

    Physiomics Plc is traded on the LSE under the ticker symbol "PYC.L".

  • What is Physiomics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Physiomics?

    Shares of Physiomics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Physiomics's key executives?

    Physiomics's management team includes the following people:

    • Dr. James Simon Millen Chief Executive Officer & Director(age: 56, pay: $146,080)
  • How many employees does Physiomics have?

    As Jul 2024, Physiomics employs 10 workers.

  • When Physiomics went public?

    Physiomics Plc is publicly traded company for more then 20 years since IPO on 20 Dec 2004.

  • What is Physiomics's official website?

    The official website for Physiomics is physiomics.co.uk.

  • How can i contact Physiomics?

    Physiomics can be reached via phone at +44 1865 784980.

Physiomics company profile:

Physiomics Plc

physiomics.co.uk
Exchange:

LSE

Full time employees:

11

Industry:

Biotechnology

Sector:

Healthcare

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.

The Magdalen Centre
Oxford, OX4 4GA

:
ISIN: GB00BDR6W943
CUSIP: G7097C113